Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin
A new once-weekly basal insulin injection demonstrated similar efficacy and safety and a lower rate of low blood sugar episodes compared with a daily basal insulin, according to a phase 2 clinical trial. The study results compared an investigational drug called basal insulin Fc (BIF) with insulin degludec, a commercially available long-lasting daily insulin, in patients with type 2 diabetes.
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/03/210321215440.htm
from Latest Science News -- ScienceDaily https://www.sciencedaily.com/releases/2021/03/210321215440.htm
Weekly insulin helps patients with type 2 diabetes achieve similar blood sugar control to daily insulin
Reviewed by cmakigo
on
March 22, 2021
Rating:
No comments:
Post a Comment